777 related articles for article (PubMed ID: 17720019)
1. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial.
Annane D; Vignon P; Renault A; Bollaert PE; Charpentier C; Martin C; Troché G; Ricard JD; Nitenberg G; Papazian L; Azoulay E; Bellissant E;
Lancet; 2007 Aug; 370(9588):676-84. PubMed ID: 17720019
[TBL] [Abstract][Full Text] [Related]
2. Catecholamine treatment for shock--equally good or bad?
Singer M
Lancet; 2007 Aug; 370(9588):636-7. PubMed ID: 17719998
[No Abstract] [Full Text] [Related]
3. Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock.
Seguin P; Bellissant E; Le Tulzo Y; Laviolle B; Lessard Y; Thomas R; Mallédant Y
Clin Pharmacol Ther; 2002 May; 71(5):381-8. PubMed ID: 12011824
[TBL] [Abstract][Full Text] [Related]
4. Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock.
Duranteau J; Sitbon P; Teboul JL; Vicaut E; Anguel N; Richard C; Samii K
Crit Care Med; 1999 May; 27(5):893-900. PubMed ID: 10362410
[TBL] [Abstract][Full Text] [Related]
5. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
[TBL] [Abstract][Full Text] [Related]
6. Double-Blind Prospective Randomized Controlled Trial of Dopamine Versus Epinephrine as First-Line Vasoactive Drugs in Pediatric Septic Shock.
Ventura AM; Shieh HH; Bousso A; Góes PF; de Cássia F O Fernandes I; de Souza DC; Paulo RL; Chagas F; Gilio AE
Crit Care Med; 2015 Nov; 43(11):2292-302. PubMed ID: 26323041
[TBL] [Abstract][Full Text] [Related]
7. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?
De Backer D; Creteur J; Silva E; Vincent JL
Crit Care Med; 2003 Jun; 31(6):1659-67. PubMed ID: 12794401
[TBL] [Abstract][Full Text] [Related]
8. THE EFFICACY AND SAFETY OF VASOPRESSORS FOR SEPTIC SHOCK PATIENTS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS.
Jia L; Wang P; Li C; Xie J
Shock; 2023 Dec; 60(6):746-752. PubMed ID: 37548686
[TBL] [Abstract][Full Text] [Related]
9. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study.
Levy B; Bollaert PE; Charpentier C; Nace L; Audibert G; Bauer P; Nabet P; Larcan A
Intensive Care Med; 1997 Mar; 23(3):282-7. PubMed ID: 9083230
[TBL] [Abstract][Full Text] [Related]
10. Vasopressin versus norepinephrine infusion in patients with septic shock.
Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
[TBL] [Abstract][Full Text] [Related]
11. Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.
Russell JA; Lee T; Singer J; De Backer D; Annane D
J Crit Care; 2018 Oct; 47():333-337. PubMed ID: 29958734
[TBL] [Abstract][Full Text] [Related]
12. Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial.
Liu ZM; Chen J; Kou Q; Lin Q; Huang X; Tang Z; Kang Y; Li K; Zhou L; Song Q; Sun T; Zhao L; Wang X; He X; Wang C; Wu B; Lin J; Yuan S; Gu Q; Qian K; Shi X; Feng Y; Lin A; He X; ; Guan XD
Intensive Care Med; 2018 Nov; 44(11):1816-1825. PubMed ID: 29971593
[TBL] [Abstract][Full Text] [Related]
13. Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study.
Morelli A; Ertmer C; Lange M; Dünser M; Rehberg S; Van Aken H; Pietropaoli P; Westphal M
Br J Anaesth; 2008 Apr; 100(4):494-503. PubMed ID: 18308741
[TBL] [Abstract][Full Text] [Related]
14. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study.
Levy B; Perez P; Perny J; Thivilier C; Gerard A
Crit Care Med; 2011 Mar; 39(3):450-5. PubMed ID: 21037469
[TBL] [Abstract][Full Text] [Related]
15. Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock.
Zhou SX; Qiu HB; Huang YZ; Yang Y; Zheng RQ
Acta Pharmacol Sin; 2002 Jul; 23(7):654-8. PubMed ID: 12100762
[TBL] [Abstract][Full Text] [Related]
16. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
Patel GP; Grahe JS; Sperry M; Singla S; Elpern E; Lateef O; Balk RA
Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
[TBL] [Abstract][Full Text] [Related]
19. Recommendations for the treatment of patients with septic shock.
Meier-Hellmann A; Reinhart K
Acta Anaesthesiol Scand Suppl; 1997; 111():177-80. PubMed ID: 9421002
[No Abstract] [Full Text] [Related]
20. Essential lessons in cardiogenic shock: epinephrine versus norepinephrine/dobutamine.
Krenn L; Delle Karth G
Crit Care Med; 2011 Mar; 39(3):583-4. PubMed ID: 21330855
[No Abstract] [Full Text] [Related]
[Next] [New Search]
